| A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus (NCT01421355) | Brigham and Women's Hospital | 2012-05-01 |
| A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus (NCT01600950) | Eli Lilly and Company | 2012-05-01 |
| Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers (NCT01720212) | Astellas Pharma China, Inc. | 2012-05-01 |
| Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects (NCT01595425) | AstraZeneca | 2012-05-01 |
| Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis (NCT01580891) | Sun Pharmaceutical Industries, Inc. | 2012-05-01 |
| Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT01562405) | Massachusetts General Hospital | 2012-05-01 |
| Phase I Study of AT13148, a Novel AGC Kinase Inhibitor (NCT01585701) | Cancer Research UK | 2012-05-01 |
| Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects (NCT01608087) | Boehringer Ingelheim | 2012-05-01 |
| Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006) (NCT01602679) | University of Virginia | 2012-05-01 |
| Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma (NCT01614301) | University of Regensburg | 2012-05-01 |
| Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition (NCT01735383) | IPCA Laboratories Ltd. | 2012-05-01 |
| Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody (NCT01594437) | Theraclone Sciences, Inc. | 2012-05-01 |
| A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma (NCT01605526) | Hoffmann-La Roche | 2012-05-01 |
| Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults (NCT01659944) | Genzyme, a Sanofi Company | 2012-05-01 |
| Fludrocortisone and Information Processing in Healthy Volunteers (NCT01648998) | Leiden University Medical Center | 2012-05-01 |
| Effect of an Iridoid Enriched Beverage on Skin Autofluorescence (NCT01597076) | Tahitian Noni International, Inc. | 2012-05-01 |
| Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran (NCT01595854) | Boehringer Ingelheim | 2012-05-01 |
| Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (NCT01530022) | UCB Pharma | 2012-05-01 |
| Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults (NCT01578889) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-01 |
| Working Memory Training in ADHD (The Engage Study) (NCT01657721) | University of Toronto | 2012-05-01 |
| AZD8848 Single Ascending Dose Study (NCT01560234) | AstraZeneca | 2012-05-01 |
| The Effect of Midazolam on Fluid Responsiveness in Septic Patients (NCT02050893) | Southeast University, China | 2012-05-01 |
| Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma (NCT01429025) | Alliance for Clinical Trials in Oncology | 2012-05-01 |
| Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus) (NCT01589185) | Aridis Pharmaceuticals, Inc. | 2012-05-01 |
| Relative Bioavailability Study (NCT01602887) | Pfizer | 2012-05-01 |
| A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT01631097) | AVEO Pharmaceuticals, Inc. | 2012-05-01 |
| Sublingual Nicotine Tablets Compared With Swedish Snus (NCT01838460) | Contract Research Organization el AB | 2012-05-01 |
| A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340 (NCT01601834) | Pfizer | 2012-05-01 |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years (NCT01596400) | Kyowa Kirin Pharmaceutical Development Ltd | 2012-05-01 |
| Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors (NCT01544322) | MEI Pharma, Inc. | 2012-05-01 |
| Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (NCT01612000) | Protein Sciences Corporation | 2012-05-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma. (NCT02206308) | Sinocelltech Ltd. | 2012-05-01 |
| Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells (NCT02123368) | Clinica Universidad de Navarra, Universidad de Navarra | 2012-05-01 |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (NCT01652794) | Case Comprehensive Cancer Center | 2012-05-01 |
| Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers (NCT01605461) | Boehringer Ingelheim | 2012-05-01 |
| Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia (NCT01558908) | Medistem Inc. | 2012-05-01 |
| A Study of A High Concentration Liquid Formulation Versus A Lyophilized Formulation of Gantenerumab in Healthy Volunteers (NCT01636531) | Hoffmann-La Roche | 2012-05-01 |
| A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435 (NCT01799603) | Janssen Research & Development, LLC | 2012-05-01 |
| Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts (NCT01608243) | Stallergenes Greer | 2012-05-01 |
| Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition (NCT01735370) | IPCA Laboratories Ltd. | 2012-05-01 |
| Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (NCT01593826) | Orion Corporation, Orion Pharma | 2012-05-01 |
| Pharmacokinetic Study of Primaquine and Pyronaridine-Artesunate in Healthy Subjects (NCT01552330) | University of Oxford | 2012-05-01 |
| A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers (NCT01618877) | UCB Pharma | 2012-05-01 |
| Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition (NCT01606059) | Daewon Pharmaceutical Co., Ltd. | 2012-05-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers (NCT01594515) | Boehringer Ingelheim | 2012-05-01 |
| A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors (NCT01617928) | AbbVie (prior sponsor, Abbott) | 2012-05-01 |
| CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01195480) | University College, London | 2012-05-01 |
| Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer (NCT01677845) | NYU Langone Health | 2012-05-01 |
| Safety and Pharmacokinetic Profile of CKD-581 (NCT01580371) | Chong Kun Dang Pharmaceutical | 2012-05-01 |
| Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study (NCT01597310) | Knopp Biosciences | 2012-05-01 |
| A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet (NCT01640093) | Janssen Research & Development, LLC | 2012-05-01 |
| Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects (NCT01651325) | Astellas Pharma Global Development, Inc. | 2012-05-01 |
| A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers (NCT01592318) | Hoffmann-La Roche | 2012-05-01 |
| A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device (NCT01721642) | Apica Cardiovascular Limited | 2012-05-01 |
| Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers (NCT01486628) | NeuroDerm Ltd. | 2012-04-30 |
| Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01551446) | Biogen | 2012-04-30 |
| Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01549769) | Biogen | 2012-04-30 |
| Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer (NCT01597193) | Pfizer | 2012-04-30 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender (NCT01687309) | GlaxoSmithKline | 2012-04-30 |
| Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function (NCT01563562) | Biogen | 2012-04-30 |
| Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions (NCT01862900) | Providence Health & Services | 2012-04-27 |
| Walnut Oral Immunotherapy for Tree Nut Allergy (NCT01546753) | University of Arkansas | 2012-04-27 |
| Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain (NCT01553916) | Washington University School of Medicine | 2012-04-26 |
| A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT01456689) | Novartis Pharmaceuticals | 2012-04-25 |
| PVSRIPO for Recurrent Glioblastoma (GBM) (NCT01491893) | Istari Oncology, Inc. | 2012-04-25 |
| Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis (NCT01585766) | MedImmune LLC | 2012-04-24 |
| A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response (NCT01577459) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-04-23 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. (NCT01587716) | GlaxoSmithKline | 2012-04-23 |
| A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients (NCT01468688) | Novartis Pharmaceuticals | 2012-04-20 |
| [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment (NCT01633255) | National Cancer Institute (NCI) | 2012-04-18 |
| Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709) | National Cancer Institute (NCI) | 2012-04-16 |
| Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers (NCT01579994) | Memorial Sloan Kettering Cancer Center | 2012-04-16 |
| Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma (NCT01492088) | Millennium Pharmaceuticals, Inc. | 2012-04-16 |
| Peripheral Vasodilation in Obese Humans (NCT02833207) | University of Wisconsin, Madison | 2012-04-16 |
| Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects (NCT01572753) | Novo Nordisk A/S | 2012-04-12 |
| Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites (NCT01956487) | GlaxoSmithKline | 2012-04-11 |
| Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects (NCT01462669) | GlaxoSmithKline | 2012-04-10 |
| Vemurafenib and White Blood Cell Therapy for Advanced Melanoma (NCT01585415) | National Cancer Institute (NCI) | 2012-04-09 |
| Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study (NCT01571037) | University of Nebraska | 2012-04-05 |
| Continuous Infusion of rhIL-15 for Adults With Advanced Cancer (NCT01572493) | National Cancer Institute (NCI) | 2012-04-04 |
| XL-184+Abiraterone in Post-Chemo CRPC (NCT01574937) | Dana-Farber Cancer Institute | 2012-04-03 |
| Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma (NCT01525069) | Washington University School of Medicine | 2012-04-03 |
| Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults (NCT01571960) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Breakthrough Dyspnea Fentanyl Study in Cancer Patients (NCT01515566) | M.D. Anderson Cancer Center | 2012-04-01 |
| ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers (NCT01598129) | Targovax Oy | 2012-04-01 |
| Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment (NCT01527929) | Sanofi | 2012-04-01 |
| Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis (NCT01563068) | Mayne Pharma International Pty Ltd | 2012-04-01 |
| Improving Ambulatory Community Access After Paralysis (NCT01570816) | Louis Stokes VA Medical Center | 2012-04-01 |
| Pancreatic Islet Transplantation Into the Gastric Submucosa (NCT01571817) | Andrew Posselt | 2012-04-01 |
| Information Provision During Early Gait Training Post Stroke (NCT02626390) | University of Southampton | 2012-04-01 |
| The Effects of LY2409021 on the Liver (NCT01588366) | Eli Lilly and Company | 2012-04-01 |
| A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris (NCT01580488) | LEO Pharma | 2012-04-01 |
| Efficacy and Safety of DLBS2411 in Healthy Volunteers (NCT01573403) | Dexa Medica Group | 2012-04-01 |
| Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) (NCT01220648) | Novartis Pharmaceuticals | 2012-04-01 |
| Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors (NCT01573780) | Roswell Park Cancer Institute | 2012-04-01 |
| A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers (NCT01588002) | Hoffmann-La Roche | 2012-04-01 |
| A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection (NCT01590654) | Gilead Sciences | 2012-04-01 |
| Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer (NCT01607554) | New Mexico Cancer Research Alliance | 2012-04-01 |
| Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (NCT01579929) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (NCT01586312) | Red de Terapia Celular | 2012-04-01 |